Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Systemic Arteries01:11

Overview of Systemic Arteries

1.8K
The human body is a complex, well-organized machine, and at the heart of its operations lies the circulatory system. This network of blood vessels, which includes systemic arteries, plays a vital role in maintaining life by transporting nutrients, oxygen, and waste products to and from cells throughout the body.
Systemic circulation is the part of the cardiovascular system that carries oxygenated blood away from the heart to the body's tissues and returns deoxygenated blood back to the...
1.8K
Overview of Systemic Veins01:11

Overview of Systemic Veins

1.1K
Systemic veins are crucial blood vessels that return deoxygenated blood from various body tissues back to the heart. There are three systemic veins that return deoxygenated blood to the heart, they are as follows.
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...
1.1K
Overview of Systemic and Pulmonary Circulation01:15

Overview of Systemic and Pulmonary Circulation

10.5K
The systemic and pulmonary circuits are crucial components of the circulatory system, working together to transport blood between the heart, lungs, and the rest of the body. The process begins with pulmonary circulation, where deoxygenated blood is pumped from the right ventricle to the lungs via the pulmonary trunk and arteries. Upon reaching the lungs, the blood becomes oxygenated and returns to the heart, specifically to the left atrium, via the pulmonary veins.
The oxygenated blood is sent...
10.5K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.9K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.9K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Evaluation of Long-Read Sequencing for Telomere Length Assessment in Human Blood and Lung Tissues.

Cells·2026
Same author

Automated high-resolution computed tomography analysis outperforms visual assessment in predicting interstitial lung disease progression in systemic sclerosis.

Rheumatology (Oxford, England)·2026
Same author

Inflammatory endotypes in immunocompromised patients with community-acquired pneumonia: a framework for treatable traits.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Global Variation in Pneumonia Epidemiology.

Clinics in chest medicine·2026
Same author

Bronchiectasis in Italy: an analysis of the EMBARC registry.

ERJ open research·2026
Same author

Home-based rehabilitation in interstitial lung disease: picturing the present and drawing the future through a systematic review of the literature.

ERJ open research·2026

Related Experiment Video

Updated: Jan 24, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.8K

Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview.

John A Mackintosh1, Anna Stainer1, Joseph L Barnett1

  • 1Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.

Seminars in Respiratory and Critical Care Medicine
|May 29, 2019
PubMed
Summary

Systemic sclerosis-associated interstitial lung disease (SSc-ILD) significantly impacts quality of life and mortality. Early identification and treatment of progressive SSc-ILD are crucial, with ongoing research for better prediction and prevention strategies.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.0K
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
12:43

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

35.9K

Related Experiment Videos

Last Updated: Jan 24, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.8K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.0K
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
12:43

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

35.9K

Area of Science:

  • Pulmonology
  • Rheumatology
  • Immunology

Background:

  • Interstitial lung disease (ILD) is a leading cause of mortality in systemic sclerosis (SSc), a multisystem autoimmune condition.
  • Accurate staging and prognostication of SSc-ILD remain challenging, impacting treatment decisions and patient outcomes.

Purpose of the Study:

  • To provide a comprehensive review of current knowledge and recent advances in the management of SSc-ILD.
  • To highlight the critical importance of identifying clinically significant SSc-ILD for timely intervention.
  • To discuss the need for improved prediction and prevention strategies for SSc-ILD progression.

Main Methods:

  • This review synthesizes evidence from landmark clinical trials and recent research in SSc-ILD.
  • It examines current treatment strategies, including those for extensive, progressive, and refractory disease.
  • The review also considers palliative approaches and the role of lung transplantation.

Main Results:

  • Evidence supports treatment for extensive/progressive SSc-ILD, while limited ILD may only require treatment in subsets of patients.
  • Advances in the last decade have improved understanding, but prediction of ILD progression requires further research.
  • Lung transplantation can be a viable option for carefully selected SSc-ILD patients.

Conclusions:

  • Effective strategies for SSc-ILD are evolving, with a focus on less toxic treatments.
  • Early prediction and prevention of SSc-ILD progression are critical unmet needs.
  • Palliative care and lung transplantation represent important considerations for advanced SSc-ILD.